{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:41:08Z","timestamp":1794458468985,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272780"],"award-info":[{"award-number":["82272780"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8216110322"],"award-info":[{"award-number":["8216110322"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-69350-y","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T19:05:50Z","timestamp":1770663950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["STING synergizes with TOX suppressing HO-1 expression to trigger ferroptosis in tumor-infiltrating CD8+ T cell and immunotherapy resistance"],"prefix":"10.1038","volume":"17","author":[{"given":"Qian","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9386-2895","authenticated-orcid":false,"given":"Jun-bao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-ping","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-ping","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5519-7164","authenticated-orcid":false,"given":"Xi-liang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4444-7472","authenticated-orcid":false,"given":"Xiao-jun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7427-6681","authenticated-orcid":false,"given":"Song","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3011-1134","authenticated-orcid":false,"given":"Xiao-shi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5596-9159","authenticated-orcid":false,"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"69350_CR1","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/s41590-024-01896-9","volume":"25","author":"CC Zebley","year":"2024","unstructured":"Zebley, C. C., Zehn, D., Gottschalk, S. & Chi, H. T cell dysfunction and therapeutic intervention in cancer. Nat. Immunol. 25, 1344\u20131354 (2024).","journal-title":"Nat. Immunol."},{"key":"69350_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41586-022-05388-4","volume":"611","author":"TW Wang","year":"2022","unstructured":"Wang, T. W. et al. Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes. Nature 611, 358\u2013364 (2022).","journal-title":"Nature"},{"key":"69350_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip, M. & Schietinger, A. CD8(+) T cell differentiation and dysfunction in cancer. Nat. Rev. Immunol. 22, 209\u2013223 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"69350_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ccell.2023.12.013","volume":"42","author":"D Memon","year":"2024","unstructured":"Memon, D. et al. Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer. Cancer Cell 42, 209\u2013224 (2024).","journal-title":"Cancer Cell"},{"key":"69350_CR5","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1158\/1078-0432.CCR-20-4405","volume":"27","author":"JJ Harding","year":"2021","unstructured":"Harding, J. J. et al. Blocking TIM-3 in treatment-refractory advanced solid tumors: a phase Ia\/b study of LY3321367 with or without an anti-PD-L1 antibody. Clin. Cancer Res. 27, 2168\u20132178 (2021).","journal-title":"Clin. Cancer Res."},{"key":"69350_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","volume":"37","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld, A. J. & Hellmann, M. D. Acquired Resistance to Immune Checkpoint Inhibitors. Cancer Cell 37, 443\u2013455 (2020).","journal-title":"Cancer Cell"},{"key":"69350_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.semcancer.2022.12.003","volume":"88","author":"M Oladejo","year":"2023","unstructured":"Oladejo, M., Paulishak, W. & Wood, L. Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines. Semin. Cancer Biol. 88, 81\u201395 (2023).","journal-title":"Semin. Cancer Biol."},{"key":"69350_CR8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","volume":"403","author":"D Lorusso","year":"2024","unstructured":"Lorusso, D. et al. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial. Lancet 403, 1341\u20131350 (2024).","journal-title":"Lancet"},{"key":"69350_CR9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.tcb.2022.11.001","volume":"33","author":"C Chen","year":"2023","unstructured":"Chen, C. & Xu, P. Cellular functions of cGAS-STING signaling. Trends Cell Biol. 33, 630\u2013648 (2023).","journal-title":"Trends Cell Biol."},{"key":"69350_CR10","doi-asserted-by":"crossref","unstructured":"Li, W. et al. cGAS-STING-mediated DNA sensing maintains CD8(+) T cell stemness and promotes antitumor T cell therapy. Sci. Transl. Med. 12, eaay9013(2020).","DOI":"10.1126\/scitranslmed.aay9013"},{"key":"69350_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41590-020-00859-0","volume":"22","author":"P Rai","year":"2021","unstructured":"Rai, P. et al. IRGM1 links mitochondrial quality control to autoimmunity. Nat. Immunol. 22, 312\u2013321 (2021).","journal-title":"Nat. Immunol."},{"key":"69350_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.immuni.2014.11.011","volume":"41","author":"Q Wang","year":"2014","unstructured":"Wang, Q. et al. The E3 ubiquitin ligase AMFR and INSIG1 bridge the activation of TBK1 kinase by modifying the adaptor STING. Immunity 41, 919\u2013933 (2014).","journal-title":"Immunity"},{"key":"69350_CR13","doi-asserted-by":"crossref","unstructured":"Somatilaka, B. N. et al. STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. J. Clin. Invest. 134, e176748 (2024).","DOI":"10.1172\/JCI176748"},{"key":"69350_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","volume":"28","author":"F Meric-Bernstam","year":"2022","unstructured":"Meric-Bernstam, F. et al. Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas. Clin. Cancer Res. 28, 677\u2013688 (2022).","journal-title":"Clin. Cancer Res."},{"key":"69350_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","volume":"29","author":"F Meric-Bernstam","year":"2023","unstructured":"Meric-Bernstam, F. et al. Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced\/metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib study. Clin. Cancer Res. 29, 110\u2013121 (2023).","journal-title":"Clin. Cancer Res."},{"key":"69350_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ado9933","volume":"10","author":"K Knox","year":"2025","unstructured":"Knox, K. et al. Dynamic STING repression orchestrates immune cell development and function. Sci. Immunol. 10, eado9933 (2025).","journal-title":"Sci. Immunol."},{"key":"69350_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4049\/jimmunol.1601999","volume":"199","author":"B Larkin","year":"2017","unstructured":"Larkin, B. et al. Cutting edge: activation of STING in T cells induces type I IFN responses and cell death. J. Immunol. 199, 397\u2013402 (2017).","journal-title":"J. Immunol."},{"key":"69350_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1084\/jem.20182192","volume":"216","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death. J. Exp. Med. 216, 867\u2013883 (2019).","journal-title":"J. Exp. Med."},{"key":"69350_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2022.10.004","volume":"193","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. Manganese induces tumor cell ferroptosis through type-I IFN dependent inhibition of mitochondrial dihydroorotate dehydrogenase. Free Radic. Biol. Med. 193, 202\u2013212 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"69350_CR20","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","volume":"42","author":"C Galassi","year":"2024","unstructured":"Galassi, C., Chan, T. A., Vitale, I. & Galluzzi, L. The hallmarks of cancer immune evasion. Cancer Cell 42, 1825\u20131863 (2024).","journal-title":"Cancer Cell"},{"key":"69350_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","volume":"571","author":"AC Scott","year":"2019","unstructured":"Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"69350_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","volume":"571","author":"O Khan","year":"2019","unstructured":"Khan, O. et al. TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion. Nature 571, 211\u2013218 (2019).","journal-title":"Nature"},{"key":"69350_CR23","doi-asserted-by":"publisher","first-page":"12410","DOI":"10.1073\/pnas.1905675116","volume":"116","author":"H Seo","year":"2019","unstructured":"Seo, H. et al. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8(+) T cell exhaustion. Proc. Natl. Acad. Sci. USA 116, 12410\u201312415 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69350_CR24","doi-asserted-by":"publisher","first-page":"10919","DOI":"10.1073\/pnas.94.20.10919","volume":"94","author":"KD Poss","year":"1997","unstructured":"Poss, K. D. & Tonegawa, S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. USA 94, 10919\u201310924 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69350_CR25","doi-asserted-by":"publisher","first-page":"6054","DOI":"10.1182\/blood-2010-03-272138","volume":"116","author":"G Kovtunovych","year":"2010","unstructured":"Kovtunovych, G., Eckhaus, M. A., Ghosh, M. C., Ollivierre-Wilson, H. & Rouault, T. A. Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood 116, 6054\u20136062 (2010).","journal-title":"Blood"},{"key":"69350_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57906-3","volume":"16","author":"H Deng","year":"2025","unstructured":"Deng, H. et al. Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer. Nat. Commun. 16, 2597 (2025).","journal-title":"Nat. Commun."},{"key":"69350_CR27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1124\/pr.119.018762","volume":"72","author":"MA Felmlee","year":"2020","unstructured":"Felmlee, M. A., Jones, R. S., Rodriguez-Cruz, V., Follman, K. E. & Morris, M. E. Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease. Pharmacol. Rev. 72, 466\u2013485 (2020).","journal-title":"Pharmacol. Rev."},{"key":"69350_CR28","doi-asserted-by":"publisher","unstructured":"Kowalczyk, J. T. et al. Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies. J. Immunother. Cancer 10, 142503 https:\/\/doi.org\/10.1136\/jitc-2022-005752 (2022).","DOI":"10.1136\/jitc-2022-005752"},{"key":"69350_CR29","doi-asserted-by":"publisher","unstructured":"Ni, H. et al. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J. Immunother. Cancer 10, https:\/\/doi.org\/10.1136\/jitc-2022-005151 (2022).","DOI":"10.1136\/jitc-2022-005151"},{"key":"69350_CR30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786\u2013791 (2013).","journal-title":"Science"},{"key":"69350_CR31","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ncb3586","volume":"19","author":"S Gl\u00fcck","year":"2017","unstructured":"Gl\u00fcck, S. et al. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat. Cell Biol. 19, 1061 (2017).","journal-title":"Nat. Cell Biol."},{"key":"69350_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature24050","volume":"550","author":"ZX Dou","year":"2017","unstructured":"Dou, Z. X. et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550, 402\u2013406 (2017).","journal-title":"Nature"},{"key":"69350_CR33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2205049120","volume":"120","author":"MJ Quaney","year":"2023","unstructured":"Quaney, M. J. et al. STING controls T cell memory fitness during infection through T cell-intrinsic and IDO-dependent mechanisms. Proc. Natl. Acad. Sci. USA 120, e2205049120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69350_CR34","doi-asserted-by":"publisher","unstructured":"Sekine, T. et al. TOX is expressed by exhausted and polyfunctional human effector memory CD8(+) T cells. Sci. Immunol. 5, https:\/\/doi.org\/10.1126\/sciimmunol.aba7918 (2020).","DOI":"10.1126\/sciimmunol.aba7918"},{"key":"69350_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407398","volume":"12","author":"AA Padhiar","year":"2025","unstructured":"Padhiar, A. A. et al. MAM-STAT3-driven mitochondrial Ca(+2) upregulation contributes to immunosenescence in type a mandibuloacral dysplasia patients. Adv. Sci. 12, e2407398 (2025).","journal-title":"Adv. Sci."},{"key":"69350_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01466-w","volume":"22","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation. Cell Commun. Signal 22, 22 (2024).","journal-title":"Cell Commun. Signal"},{"key":"69350_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41392-025-02216-9","volume":"10","author":"X Wang","year":"2025","unstructured":"Wang, X. et al. STING aggravates ferroptosis-dependent myocardial ischemia-reperfusion injury by targeting GPX4 for autophagic degradation. Signal Transduct. Target. Ther. 10, 136 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"69350_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.immuni.2009.01.008","volume":"30","author":"B Zhong","year":"2009","unstructured":"Zhong, B. et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 30, 397\u2013407 (2009).","journal-title":"Immunity"},{"key":"69350_CR39","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1182\/blood.2020008455","volume":"139","author":"AV Menon","year":"2022","unstructured":"Menon, A. V. et al. Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease. Blood 139, 936\u2013941 (2022).","journal-title":"Blood"},{"key":"69350_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun, X. et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63, 173\u2013184 (2016).","journal-title":"Hepatology"},{"key":"69350_CR41","doi-asserted-by":"publisher","first-page":"F702","DOI":"10.1152\/ajprenal.00044.2017","volume":"314","author":"O Adedoyin","year":"2018","unstructured":"Adedoyin, O. et al. Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells. Am. J. Physiol. Renal. Physiol. 314, F702\u2013F714 (2018).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"69350_CR42","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"69350_CR43","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 33, 1001\u20131012.e1005 (2021).","journal-title":"Cell Metab."},{"key":"69350_CR44","doi-asserted-by":"publisher","unstructured":"Raynor, J. L. & Chi, H. B. Nutrients: Signal 4 in T cell immunity. J. Exp. Med. 221, https:\/\/doi.org\/10.1084\/jem.20221839 (2024).","DOI":"10.1084\/jem.20221839"},{"key":"69350_CR45","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors. Immunity 54, 1561\u20131577 (2021).","journal-title":"Immunity"},{"key":"69350_CR46","doi-asserted-by":"publisher","first-page":"216896","DOI":"10.1016\/j.canlet.2024.216896","volume":"591","author":"E Dai","year":"2024","unstructured":"Dai, E., Wang, W., Li, Y., Ye, D. & Li, Y. Lactate and lactylation: Behind the development of tumors. Cancer Lett. 591, 216896 (2024).","journal-title":"Cancer Lett."},{"key":"69350_CR47","doi-asserted-by":"publisher","unstructured":"Quinn, W. J. et al. Lactate Limits T Cell Proliferation via the NAD(H) Redox State. Cell Rep. 33, https:\/\/doi.org\/10.1016\/j.celrep.2020.108500 (2020).","DOI":"10.1016\/j.celrep.2020.108500"},{"key":"69350_CR48","doi-asserted-by":"publisher","unstructured":"Lopez, E. et al. Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignancies. J. Immunother. Cancer 11, https:\/\/doi.org\/10.1136\/jitc-2022-006287 (2023).","DOI":"10.1136\/jitc-2022-006287"},{"key":"69350_CR49","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand, A. et al. LDHA-Associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24, 657\u2013671 (2016).","journal-title":"Cell Metab."},{"key":"69350_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl4089","volume":"390","author":"JM Hsu","year":"2025","unstructured":"Hsu, J. M. et al. MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists. Science 390, eadl4089 (2025).","journal-title":"Science"},{"key":"69350_CR51","doi-asserted-by":"publisher","unstructured":"Zhang, H. et al. Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity. J. Clin. Invest. 135, https:\/\/doi.org\/10.1172\/jci180622 (2025).","DOI":"10.1172\/jci180622"},{"key":"69350_CR52","doi-asserted-by":"crossref","unstructured":"Girard, M. et al. STING agonists drive recruitment and intrinsic type I interferon responses in monocytic lineage cells for optimal anti-tumor immunity. J. Immunol. 214, 3634\u20133646 (2025).","DOI":"10.1093\/jimmun\/vkaf131"},{"key":"69350_CR53","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","volume":"564","author":"JM Ramanjulu","year":"2018","unstructured":"Ramanjulu, J. M. et al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature 564, 439\u2013443 (2018).","journal-title":"Nature"},{"key":"69350_CR54","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.cell.2024.03.037","volume":"187","author":"H Chi","year":"2024","unstructured":"Chi, H., Pepper, M. & Thomas, P. G. Principles and therapeutic applications of adaptive immunity. Cell 187, 2052\u20132078 (2024).","journal-title":"Cell"},{"key":"69350_CR55","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1158\/1078-0432.CCR-22-2103","volume":"28","author":"MS Hall","year":"2022","unstructured":"Hall, M. S. et al. Combination nivolumab, CD137 agonism, and adoptive cell therapy with tumor-infiltrating lymphocytes for patients with metastatic melanoma. Clin. Cancer Res. 28, 5317\u20135329 (2022).","journal-title":"Clin. Cancer Res."},{"key":"69350_CR56","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2340\/1651-226X.2024.40495","volume":"63","author":"JM L\u2019Orphelin","year":"2024","unstructured":"L\u2019Orphelin, J. M. et al. NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial. Acta Oncol. 63, 867\u2013877 (2024).","journal-title":"Acta Oncol."},{"key":"69350_CR57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0079-6603(01)67026-0","volume":"67","author":"SM Cohen","year":"2001","unstructured":"Cohen, S. M. & Lippard, S. J. Cisplatin: from DNA damage to cancer chemotherapy. Prog. Nucleic Acid Res. Mol. Biol. 67, 93\u2013130 (2001).","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"69350_CR58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"69350_CR59","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"69350_CR60","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive Integration of Single-Cell Data. Cell 177, 1888\u20131902 (2019).","journal-title":"Cell"},{"key":"69350_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105123","volume":"25","author":"C Xu","year":"2022","unstructured":"Xu, C. et al. Comprehensive multi-omics single-cell data integration reveals greater heterogeneity in the human immune system. iScience 25, 105123 (2022).","journal-title":"iScience"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69350-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69350-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69350-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:02:58Z","timestamp":1773838978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69350-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69350"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69350-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2543"}}